MEX3A and ovarian carcinoma: The development of novel small-molecule inhibitors of MEX3A or the targeted inhibition of MEX3A expression using methods such as MEX3A blocking peptide, ASO, or AAV would suppress the growth and metastasis of ovarian cancer cells and improve the clinical prognosis of patients.